Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul

If todays RNS does not pull Deltex out of the mire, nothing will.

The management have to shout the results of this study as loud as they can, they must not sit back, watch and wait for people to read it, otherwise it will languish along with all those previous studies.

Come on Deltex, there is a great opportunity here, don't waste it!!!!

I now think that Deltex have reached a crossroads, they will either have to

1 Sell out.
2 Enter a partnership.
or
3 Change their tactics from passive selling to more aggressive selling.

Meanwhile as I do not see the sp dropping further due to a possibility of one of the above scenarios I have just bought a few more, something over the last few years I thought I would never do.

Is the tortoise becoming more hare!

Strangely enough as we have not had a RNS this month after a nice few since Sept, I awaited 0700 hrs this morning with anticipation, something I did not dream I would be doing regarding Deltex as several months can easily drift by without any hint of a contract.

But as this mornings RNS states, 'These are the fifth and sixth new platform programme accounts that Deltex has secured since September bringing the total number of US platform accounts to 17, including 11 new ones in the year to date'.

So credit where credits due and it looks like my top up 7 days ago might just pay off.

It is starting to look as if the company will make it good on it's own, better late than never.

Can't remember how many years since I last put a buy rec on this share!

EDIT.......Market been open 45 mins and not one single trade, just shows how the market has stopped watching Deltex, good opportunity going here.

RNS,

So investors are to be offered shares at 4p.

By the time these shares are accepted for trading I would think that there is a very good chance the shares which closed last night at 4.62p will be either on par or could be even lower.

Although I have been more positive of late than I have been for ages, I will not be taking part as I think yet another dilution of company value, is a gamble too far.

If you look at share performance over the last 2 weeks (chart attached), the shares have fallen almost 20% and the market still falling won't help steady the price.

">

Todays RNS re EIS.

No doubt this incentive will encourage some to take up shares in the offer, although I am still not tempted.

It is now 3.9p to buy, not looking good for the offer.

I hope for the companies sake as well as for investors of course, that the sp rises at least to 5p, but looking at the markets and the risk stories doing the rounds, less than 4p could be the price for a while.

Other events aside, Markets are at best "Waiting for something" - and probably not too good - but the situation in this co - Is that good?
I'm wary of Co that don't sell into the UK - it's v.difficult to know what Buyers think . . . but if US Hospitals are buying then there are plenty more that can use Deltex probes . . . . that's good.... Although rather too slow in happening!

The sp is just below the Offer price( = 4p - DYOR ), but they have this Loan Note to replay - why diidn't they raise that money by a Offer ( like this one)..? Paying that Fund 8% p.a. over 3-years looks careless, but presumably they thought it wouldn't affect the sp...?

Dunno - I may still buy a few - ( it's an Av. Dn. ), and What of the Future?
-does anyone think this will see 20p - even in the next 3-years?

Then, for that dosh, I can W,W&S and enjoy those memories . . .

Hi Hangon,

We may well see 20p again, but to my mind there have seen too many false dawns to be drawn in again to buy more shares.

Result of the fund raising.

Deltex has received valid acceptances from Qualifying Shareholders in respect of 10,693,408 Open Offer Shares, including applications for 6,303,861 Open Offer Shares under the Excess Application Facility. This represents approximately 57.0 per cent. of the maximum Open Offer Shares available under the Open Offer.

The low take up says it all regarding the lack of confidence in the companies future.

The last similar fund raiser for another IAM company I am invested in was around 4 times over subscribed and yet the sp is now lower in that company than it was a month ago, the date of the offer, which does not bode well for a company that's offer was under subscribed.

It matters little what individuals think, positive or negative, it's the collective of 43.0 per cent that the market will concentrate on.

I expect the sp to drop by .25 to .50p by close today.

greekman, I fear you may be right, but the sp has risen since the "uncertainty" they'd get anything . . . . so I guess the money raised "should" be spent carefully.... However, they've not used it to make profits in the past, so while I subscribed a little, I'm only "hopeful"
They are supplying decent "Kit" - but it's into the US so difficult o understand exactly how they are meeting expectations . . . from this end it's not good and they really need to develop extra kit . . . and not just the same in pink/chrome etc.
Execs need to spend some time in the US to discover what Kit is missing - and satisfy that need - pref. something reasonably simple with a small customer-base ( This avoids being overloaded with demand, allowing Competition in. ).... pref. it would be something that's unrelated to existing kit, but which is "At home" in a hospital
environment; so their limited Sales-Force can sell "twice-per-trip".

I wonder - did the Issue cover the Debt they wanted to clear?
+ I suspect the Issue wasn't a "good-enough deal" to excite larger Shareholders.... so the Advisors badly misjudged the Market - it's particularly tough at this time.

Yr comments re other Co. placings . . .
Were they in the Hype regions, I wonder?
Folks can pay silly money for stocks without L-T track records
- whereas Deltex has one that's clearly getting worse! Er, IMHO. and I suspect that was why it only got half the amount.
EDIT-(5April2016)- Low take-up is also a factor of the prevailing mind-set . . . with folks thinking China may implode and US in Debt too, it's possible that for Deltex folks are unduly worried....but all-in-all I fear Deltex needs mind-changing at the TOP. . . and this 2016-money will go the same way as previous Dilution.
Sadly I have little regard for this business and the sp rather agrees with that.
The fact is they can't sell this in the UK - so why don't they make something that does sell - thereby their profits "could" be spent on Investors+Reserach . . . although I get the impression there is minimal Research . . . as they believe the path to Riches only needs finding the right clothing . . . whereas I think a decent Map and GPS would be more useful.
EDIT-(11May2016).Release of new WA probe in the UK ( Yet available in US, since Nov"15)....ah well they needed somewhere to place the older product. . . . sp 3.38p
EDIT-(22May2016)-sp up 16%, but still below 5p.
EDIT (03Oct2016) Greekman - re. partnering/probes....Sphere looks promising...?
EDIT (3Nov2016)-sp+10% (~3.5p) on Southern NHS buying £30K-worth . . . Huh!
EDIT (17Nov2016)-Greekman, it's small pots...but does indicate they can break into fresh ground - if NHS continues to by "probes" then / more / elsewhere in UK.
EDIT(7Nov2016)-7% fall today, are the rats leaving already? What I fail to understand is why whoever designed probes+m/c hasn't thought of ANOther product, which would add to Sales and Medic-Interest. Yr point about "partnering" I would change to "Agent" - where they take a 'related' product ( so the same salesforce needs only minor training ), from a Company that isn't active (or too Small) in D's territories. This is beneficial to both parties, esp. [DEMG]. if they can rebrand -OR- if the Probes m/c can be used to power/display Both products. When I was working for Co's- they were open to Customer needs, that's the way to best conduct "research" - no point in developing Kit that no-one wants/Afford.... The probe/NHS link is slightly good.....but look at the "Time" it's taken. Are the Sales-force part-timers? Too many Execs aren't out selling! IMHO.
EDIT (7March2017)-sp 3.6p doesn't look like Mkt believes there's much Prospect... Oh dear!
EDIT ( 26May2017)- sp 4p1 It rose on news they're offering "Veterinary" probes ( Dogs/Cats ), which is another Market-stream . . . . also "owners" may wish to have the best-chance of success, etc. Pity they can't do Horses - that's where real money lies, but maybe they just shoot them? Dunno. It's much better than "no-News"
EDIT (11July2017)- sp 3.6 looks like it's not recovering... & News re Korea?
EDIT(21Sept2017)- Seems they've sold two "xxx" to France. sp 3.16 though Dirs seem to be buying - but not £100k-worth.

Hi Hangon,

Fully agree re other kit, which means I have to comment on my old chestnut re Deltex partnering, but as you know I have mentioned it so many times.

As for the other companies placings, not really in the hype area as they have the backing of some very big players.

I do though agree that over subscribe does not always mean that the future is rosy, thinking about tech companies for example.

As this is the first post of over 7 months it just goes to show how interest has almost completely faded in Deltex.

As to todays RNS, it is again tea tin change money, but anything to do with the NHS taking monitors and probes has to be encouraging.

This shares price has a trend of sinking like the proverbial lead balloon.

I see the announcement re: Korea, and the fact that Deltex thinks that their Korean sales will go from £0.3m last year to £0.6m this year.


I note that, in the announcement, Deltex says that the Korean decision refers specifically to ODM and not to any other kind of monitoring. Oh, dear, that means that Lidco can't try to claim that it applies to them.

Directors buying

What a pathetic end to the year. This time last year I thought things could not get worse and yet the sp has almost halved again.

It's no surprise €l Greco, this about sums them up.

Trading Update.

The following says it all.

Overall revenues of £5.9m (2016 £6.3m)
International revenues down by 5%
UK revenues reduced by 18%
December sales were down with c.£0.3m of bulk orders not repeated from 2016
Loss for 2017 expected to be higher than market expectations
Cash at 31 December of £0.2m (2016: £0.6m).

The rest means nothing, because they said almost the same, word for word at the same time last year................And it changed nothing..............................

Discussions on the future funding of the Group are in progress and the Company expects to be able to make a further announcement in the near future(again).

However, Deltex enters 2018 positioned to benefit from momentum in the USA and other focus export markets. The UK continues to be a difficult market due to NHS funding constraints (change enters 2018 for 2017 and its same again).

We have substantially reduced our rate of operating cash consumption (again)

The Company is currently in the implementation phase of achieving this goal in a number of territories worldwide, operating directly in the UK, USA, Spain and Canada and through distribution arrangements in a further 30 countries. (again, bla bla bla)

I would not be surprised if the sp by end of year (if the company is still quoted) as being a true 1p share, or lower).

Absolutely pathetic..........Albert Einstein was right, perhaps he knew about Deltex.

Came as a bit of a shock ( 46% fall =yes, - well almost), reading News on M-AM today, [ sp=1p ], =Oh deary, dear. Well I guess this could be the end; as the Market gives up all hope that any future money will go the same way. Quite apart from Greekman... I believe they should be concentrating on the UK market - you get that right and supply elsewhere is a bonus. It's true the NHS is penny-pinching and might not be a big spender.... so why not apply their "Development" to an area where there are willing customers? This may mean making something completely different . . . . but why not? Let the Sales of existing kit continue, with minimal spend.... while concentrating on the Next Big Thing. Clearly, the Sales for their Blood-pressure kit is insuficent to keep the Co. going. . . .
This I has been the fact for many years....only Execs fail to see it....and from the Co-Speak it remains, so.
/
Greekman - I kinda agree, but trying to tackle the NHS is a No-No from the start as they only deal with suppliers "on the list" ( the partnering which you suggested only spreads the profits). Whilst it may be true there are no "Private Healthcare" operative that would sustain this business...fact is even World-wide they are struggling for meaningful sales . . . and until then the daily costs represent enormous losses. They need to get into a product-line that is WANTED.... quite simple, but they are focussed only on selling probes . . . and that's difficult.

Hi Hangon,

re concentrating on the Uk market..............the problem was/is that they did concentrate on the UK market for years and they got almost nowhere, in fact if they had not spread their wings to foreign shores, they would have already gone bust.

Deltex's problem, especially with the UK market is they have always required a hammer to crack the home market, but instead of partnering (which many small medical equipment companies do) they stubbornly refused to consider such a move and were left trying to break into the market with a toffee hammer, where a sledgehammer was needed.